This inventor holds 1 USPTO granted patent. Top assignee: Memorial Sloan Kettering Cancer Center. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Weilin Sun: Innovator in Cancer Research
Introduction
Weilin Sun is a prominent inventor based in New York, CN. He has made significant contributions to the field of cancer research, particularly through his innovative work on selective GRP94 inhibitors.
Latest Patents
Weilin Sun holds a patent titled "Selective GRP94 Inhibitors and Uses Thereof." This patent reflects his dedication to developing new therapeutic strategies for cancer treatment. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Weilin Sun is affiliated with the Memorial Sloan Kettering Cancer Center, a leading institution in cancer research and treatment. His work at this prestigious center has allowed him to focus on groundbreaking research that aims to improve patient outcomes.
Collaborations
One of his notable collaborators is Gabriela Chiosis, with whom he has worked on various projects related to cancer therapies. Their partnership exemplifies the collaborative spirit that drives innovation in the medical field.
Conclusion
Weilin Sun's contributions to cancer research through his patent and work at Memorial Sloan Kettering Cancer Center highlight his role as an influential inventor in the medical community. His ongoing efforts continue to inspire advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile